Cover Image
市場調查報告書

心肌病:全球臨床實驗檢討

Cardiomyopathy Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 167035
出版日期 內容資訊 英文 198 Pages
訂單完成後即時交付
價格
Back to Top
心肌病:全球臨床實驗檢討 Cardiomyopathy Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 198 Pages
簡介

本報告提供心肌病相關臨床研究的最新趨勢相關分析,為您彙整疾病治療方法概要,及臨床實驗的主要國家,G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 心肌病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國對臨床實驗數量:心血管系統疾病臨床實驗數量上,心肌病臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7國)對臨床實驗數量:心血管系統疾病臨床實驗數量上,心肌病臨床實驗數量所佔的比例

E7各國(新興7國)臨床實驗數量:Phase別

E7各國(新興7國)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Johnson & Johnson
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • Les Laboratoires Servier SAS
    • Celladon Corporation
    • Aastrom Biosciences, Inc.
    • Bayer AG
    • Array BioPharma Inc.
    • AAVLife
    • A. Menarini Industrie Farmaceutiche Riunite Srl
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • University of Pittsburgh
    • Johns Hopkins University
    • Assistance Publique - Hopitaux de Paris
    • University of Michigan
    • 大阪大學
    • Maastricht University Medical Center
    • University Health Network
    • Johann Wolfgang Goethe University Hospitals
    • Stanford University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4243CTIDB

GlobalData's clinical trial report, "Cardiomyopathy Global Clinical Trials Review, H1, 2017" provides an overview of Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Cardiomyopathy Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Latest Clinical Trials News on Cardiomyopathy 29
  • May 30, 2017: Poxel to Present New Preclinical Imeglimin Data on Protective Benefits from Diabetic Cardiomyopathy at the American Diabetes Association Meeting 29
  • Clinical Trial Profile Snapshots 30

Appendix 196

  • Abbreviations 196
  • Definitions 196
  • Research Methodology 197
  • Secondary Research 197
  • About GlobalData 198
  • Contact Us 198
  • Source 198

List of Tables

List of Tables

  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
  • Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 17
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
  • Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 17
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 197
Back to Top